跳至主要内容
临床试验/NCT06159764
NCT06159764招募中不适用

National Registry of Cardioneuroablation in Recurrent Reflex Syncope

University Hospital, Bordeaux14 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年11月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
14
主要终点
Recurrence of vasovagal syncope

研究概览

简要总结

This registry aims to collect patient data on cardioneuroablation for vasovagal syncope from multiple centers in France. The aim is to evaluate success rates, compare techniques and help institutions set up their own cardioneuroablation program

详细描述

Cardioneuroablation is an emerging technique used to treat patients with vagally-mediated extrinsic bradycardia. It seems particularly efficient in patients with recurrent vasovagal syncope due to a strong cardioinhibitory effect. The procedure consists in using radiofrequency ablation to destroy cardiac ganglionated plexi located in epicardial fat pads around the atrias. Key questions concerning this procedure still remain unanswered: 1) What is the success rate of the procedure 2) Which patients will benefit from this technique? 3) Which fat pads should be targeted during the procedure? 4) What is the best way of identifying the location of these fat pads? 5) What are the long-term effects of this procedure? A multicenter registry seems ideal to try to answer these questions at minimal cost

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 or more
  • Recurrent vasovagal syncope (≥2 episodes during the last year) with an asystolic component (≥3 second pause) recorded during a spontaneous episode. The asystole can be related to sinus arrest or paroxysmal AV block.
  • Scheduled cardioneuroablation procedure
  • Estimated residual battery life ≥ 1 year.
  • Patient affiliated to or beneficiary of national health security scheme.
  • Patient who have received an information notice and has not objected to the use of their data in the registry.

排除标准

  • Contraindication to anticoagulation therapy: major bleeding, risk of major bleeding, severe hepatic disease
  • Contraindication to cardiac CT: contrast medium allergies
  • Intracardiac thrombus
  • Patient detained by judicial or administrative decision.

结局指标

主要结局

Recurrence of vasovagal syncope

时间窗: 12 months

Number of patients with recurrence

次要结局

  • Recurrence of vasovagal syncope in different subgroups(12 months)
  • Efficacy of cardioneuroablation procedure(12 months)
  • prevalence of post-ablation pre-syncopal events(12 months)
  • correlation between ablation sites and epicardial fat pads(12 months)
  • Quality of life of post-ablated patients (Score 1)(12 months)
  • Quality of life of post-ablated patients (Score 2)(12 months)
  • Assessment of technical learning curve by centre(12 months)

研究者

发起方
University Hospital, Bordeaux
申办方类型
Other
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验